Omeros Corporation

Company Profile

Omeros Corporation had its IPO on 2009-10-08 under the ticker symbol OMER.

The company operates in the Healthcare sector and Biotechnology industry. Omeros Corporation has a staff strength of 196 employees.

Stock update

Shares of Omeros Corporation opened at $3.42 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $3.29 - $3.46, and closed at $3.32.

This is a -3.49% slip from the previous day's closing price.

A total volume of 279,543 shares were traded at the close of the day’s session.

In the last one week, shares of Omeros Corporation have slipped by -6.21%.

Omeros Corporation's Key Ratios

Omeros Corporation has a market cap of $215.91 million, indicating a price to book ratio of 8.4414 and a price to sales ratio of 4.9338.

In the last 12-months Omeros Corporation’s revenue was $-30004000 with a gross profit of $-71397000 and an EBITDA of $-166516000. The EBITDA ratio measures Omeros Corporation's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Omeros Corporation’s operating margin was 0% while its return on assets stood at -23.98% with a return of equity of -728.71%.

In Q2, Omeros Corporation’s quarterly earnings growth was a positive 0% while revenue growth was a positive 14.9%.

Omeros Corporation’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

-0.17

Its diluted EPS in the last 12-months stands at $-3 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of -0.17. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Omeros Corporation’s profitability.

Omeros Corporation stock is trading at a EV to sales ratio of 8.26 and a EV to EBITDA ratio of -1.5145. Its price to sales ratio in the trailing 12-months stood at 4.9338.

Omeros Corporation stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$527.42 million

Total Liabilities

$143.54 million

Operating Cash Flow

$35.38 million

Capital Expenditure

$275000

Dividend Payout Ratio

0%

Omeros Corporation ended 2024 with $527.42 million in total assets and $0 in total liabilities. Its intangible assets were valued at $527.42 million while shareholder equity stood at $20.51 million.

Omeros Corporation ended 2024 with $0 in deferred long-term liabilities, $143.54 million in other current liabilities, 628000.00 in common stock, $-706712000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $6.60 million and cash and short-term investments were $341.28 million. The company’s total short-term debt was $99,416,000 while long-term debt stood at $221.52 million.

Omeros Corporation’s total current assets stands at $388.56 million while long-term investments were $0 and short-term investments were $334.68 million. Its net receivables were $40.27 million compared to accounts payable of $9.55 million and inventory worth $0.

In 2024, Omeros Corporation's operating cash flow was $35.38 million while its capital expenditure stood at $275000.

Comparatively, Omeros Corporation paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$3.32

52-Week High

$7.8

52-Week Low

$1.735

Analyst Target Price

$7

Omeros Corporation stock is currently trading at $3.32 per share. It touched a 52-week high of $7.8 and a 52-week low of $7.8. Analysts tracking the stock have a 12-month average target price of $7.

Its 50-day moving average was $4.28 and 200-day moving average was $4.27 The short ratio stood at 24.35 indicating a short percent outstanding of 0%.

Around 402.2% of the company’s stock are held by insiders while 3389% are held by institutions.